{"SPADE_UN_07045": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2012/0157374 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2012_0157374_A1", "Patent Type": "Patent Application", "Publication Date": "2012-6-21", "Family Info": "EP2269627A1,EP2442823A1,WO2010146067A1", "Patent Title": "Nodule specific medicago peptides having antimicrobial activity and pharmaceutical compositions containging the same.", "Abstract": "The present invention relates to the use of at least one peptide originated from Medicago truncatula nodules, including the SEQ IDs NO: 1-463 or at least one peptide having a sequence derived from the SEQ IDs NO: 1-463 by deletion of about 9 to about 44 contiguous amino acids, from the N-terminal part of the peptide, in particular peptides having the SEQ IDS NO: 464 to 925, for the preparation of a drug intended for the treatment of human, animal or plant diseases induced by microorganisms, wherein the peptides have a broad-spectrum and fast antibiotic activity, in particular killing of the bacteria within 1 to 3 hours."}], "Sequence Information": {"SPADE ID": "SPADE_UN_07045", "Sequence": "MTHISMFVYSLIIFLSIYLVVTDGIILCKDHFDCYENIRKLRCDFDTEKPFCISLNVCQCIKQ", "Sequence Length": 63, "Peptide Name": "Sequence 409 from Patent US 20120157374", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial"], "Frequent Amino Acids": "ICL", "Absent Amino Acids": "AOUW", "Basic Residues": 8, "Acidic Residues": 7, "Hydrophobic Residues": 30, "Polar Residues": 32, "Positive Residues": 8, "Negative Residues": 7, "Mass": 7441.8, "PI": 6.0, "Net Charge": 1, "Hydrophobicity": 0.51, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_07497", "Similarity": 1.0, "Sequence": "IILCKDHFDCYENIRKLRCDFDTEKPFCISLNVCQCIKQ"}, {"SPADE_ID": "SPADE_UN_06951", "Similarity": 0.6290322580645161, "Sequence": "MNHISKFVYALIIFLSIYLVVLDGLPISCKDHFECRRKINILRCIYRQEKPMCINSICTCVKLL"}, {"SPADE_ID": "SPADE_UN_06696", "Similarity": 0.5806451612903226, "Sequence": "MTHIFKFVYALIIFLSIYVAVNDCIRIHCKDDFDCIENRLQVGCRLQREKPRCVNLVCRCLRR"}]}}}